CN111423381A - Preparation method of 2-trifluoromethyl substituted imidazole compound - Google Patents

Preparation method of 2-trifluoromethyl substituted imidazole compound Download PDF

Info

Publication number
CN111423381A
CN111423381A CN202010055490.0A CN202010055490A CN111423381A CN 111423381 A CN111423381 A CN 111423381A CN 202010055490 A CN202010055490 A CN 202010055490A CN 111423381 A CN111423381 A CN 111423381A
Authority
CN
China
Prior art keywords
trifluoromethyl
imidazole compound
substituted imidazole
substituted
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010055490.0A
Other languages
Chinese (zh)
Other versions
CN111423381B (en
Inventor
吴小锋
陈铮凯
王伟丰
杨合肥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University of Technology ZJUT
Zhejiang Sci Tech University ZSTU
Zhejiang University of Science and Technology ZUST
Original Assignee
Zhejiang University of Technology ZJUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University of Technology ZJUT filed Critical Zhejiang University of Technology ZJUT
Priority to CN202010055490.0A priority Critical patent/CN111423381B/en
Publication of CN111423381A publication Critical patent/CN111423381A/en
Application granted granted Critical
Publication of CN111423381B publication Critical patent/CN111423381B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses a preparation method of a 2-trifluoromethyl substituted imidazole compound, which comprises the following steps: adding a palladium catalyst, a ligand, a carbon monoxide substitute, an additive, trifluoroethylimidoyl chloride, propargylamine and diaryl iodide into an organic solvent, reacting for 18-20 hours at 30 ℃, and after the reaction is completed, carrying out post-treatment to obtain the 2-trifluoromethyl-substituted imidazole compound. The preparation method is simple to operate, the initial raw materials are cheap and easy to obtain, the reaction efficiency is high, the substrate compatibility is good, and diversified substituted imidazole compounds with trifluoromethyl can be synthesized through substrate design, so that the practicability of the method is widened while the operation is convenient.

Description

Preparation method of 2-trifluoromethyl substituted imidazole compound
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a preparation method of a 2-trifluoromethyl substituted imidazole compound.
Background
Imidazole compounds are important nitrogen-containing five-membered heterocycles and are widely present in various molecular backbones with important biological activities (Med. Res. Rev.2014,34, 340-one 437). Many drugs and functional material molecules contain imidazole molecular structures. Imidazole compounds can also be used as ionic liquids and ligands for coordination to metals, and are often used in the field of coordination catalysis (chem.Soc.Rev.2017,46, 4845-one 4854). The introduction of trifluoromethyl into a heterocyclic molecule has many advantages, such as significantly improved electronegativity, bioavailability, metabolic stability, lipophilicity, etc. of the parent molecule (j.med. chem.2015,58, 8315-.
Figure BDA0002372646980000011
The literature reports now that the method for synthesizing nitrogen-containing heterocycles with trifluoromethyl functional groups is mainly to directly obtain trifluoromethyl-substituted nitrogen-containing heterocycles by reacting a synthon with a trifluoromethyl group with a suitable substrate (Angew. chem. int. Ed.2018,57, 6633-containing 6637; chem. Commun.2015,51, 8789-containing 8792). Among them, the more commonly used trifluoromethyl synthons are trifluorodiazoethane and trifluoroethylimidoyl halide, which are relatively not widely used at present, but have a great application potential and need to be studied deeply.
Based on the method, cheap and easily-obtained trifluoroethyliminato chloride, propargylamine and diaryl iodide are used as starting materials, and carbonylation series reaction catalyzed by transition metal palladium is used for efficiently synthesizing the 2-trifluoromethyl substituted imidazole.
Disclosure of Invention
The invention provides a preparation method of a 2-trifluoromethyl substituted imidazole compound, which has the advantages of simple steps, cheap and easily obtained reaction raw materials, compatibility with various functional groups and good reaction applicability, can be expanded to gram level, and provides possibility for industrial large-scale production and application.
A method for preparing a 2-trifluoromethyl-substituted imidazole compound, comprising the steps of: adding a mixture of palladium chloride, triphenylphosphine, sodium bicarbonate, acetic anhydride and formic acid, trifluoroethylimidoyl chloride, propargylamine and diaryl iodide into an organic solvent, reacting at 30 ℃ for 16-24 hours, and after the reaction is completed, performing post-treatment to obtain the 2-trifluoromethyl-substituted imidazole compound;
the structure of the trifluoroethylimidoyl chloride is shown as a formula (II):
Figure BDA0002372646980000021
the propargylamine has a structure shown in a formula (III):
Figure BDA0002372646980000022
the structure of the diaryl iodonium salt is shown as the formula (IV):
Figure BDA0002372646980000023
the 2-trifluoromethyl substituted imidazole compound has a structure shown in a formula (I):
Figure BDA0002372646980000024
in the formulas (I) to (IV), R is substituted or unsubstituted aryl;
ar is a substituted or unsubstituted aryl group;
the substituent on the aryl is selected from C1~C5Alkyl, halogen, trifluoromethyl or nitro.
The molar ratio of the palladium chloride to the triphenylphosphine to the sodium bicarbonate is 0.05:0.1: 2;
the substitution position on the aryl of R and Ar can be ortho, para or meta.
The reaction formula is as follows:
Figure BDA0002372646980000031
during the reaction, an intermolecular carbon-nitrogen bond promoted by alkali may be formed to obtain a trifluoroacetamidine compound, then isomerization is carried out, palladium-catalyzed alkyne amine is subjected to palladation to obtain an alkenyl palladium intermediate, then isomerization is carried out to obtain an alkyl palladium intermediate, then carbonylation reaction is carried out under the action of carbon monoxide released from formic acid acetic anhydride to obtain an acyl palladium intermediate, diaryl iodonium salt is subjected to oxidation addition to obtain a tetravalent palladium intermediate, and finally reduction elimination is carried out to obtain the final 2-trifluoromethyl-substituted imidazole compound.
In the present invention, the optional post-processing procedure includes: filtering, mixing the sample with silica gel, and finally performing column chromatography purification to obtain the corresponding 2-trifluoromethyl substituted imidazole compound, wherein the column chromatography purification is a technical means commonly used in the field.
Preferably, R is a substituted or unsubstituted aryl group, and the substituent on the aryl group is selected from methyl, tert-butyl, chlorine, bromine, trifluoromethyl or nitro, in which case the trifluoroethylimidoyl chloride is readily available and the yield of the reaction is high.
Preferably, Ar is a substituted or unsubstituted aryl group, in which case the diaryliodonium salt is readily available and the yield of the reaction is high.
The aromatic amine used to prepare the trifluoroethylimidoyl chloride is relatively inexpensive, widely available in nature, in excess relative to the propargylamine, preferably, in molar amounts, trifluoroethylimidoyl chloride: propargylamine: diaryl iodonium salts: palladium chloride is 1-3: 1: 1-3: 0.02-0.1; as a further preference, the molar amount of trifluoroethylimidoyl chloride: propargylamine: diaryl iodonium salts: palladium chloride ═ 1.5:1:1.5: 0.05.
Preferably, the reaction time is 16-24 hours, and if the reaction time is too long, the reaction cost is increased, and on the contrary, the completeness of the reaction is difficult to ensure.
In the present invention, the organic solvent capable of sufficiently dissolving the raw material can cause the reaction, but the difference in reaction efficiency is large, and the aprotic solvent is preferably an aprotic solvent which can effectively promote the reaction; preferably, the organic solvent is tetrahydrofuran, acetonitrile or dioxane; further preferably, the organic solvent is tetrahydrofuran, in which case various starting materials can be converted into products with high conversion.
The amount of the organic solvent can be used for better dissolving the raw materials, and the amount of the organic solvent used for 1mmol of trifluoroethylimidoyl chloride is about 5-10 m L.
Preferably, the catalyst is palladium chloride, which is relatively inexpensive among many palladium catalysts, and the reaction efficiency is high when palladium chloride is used as the catalyst.
As a further preference, the 2-trifluoromethyl-substituted imidazole compound is one of compounds represented by the formulae (I-1) to (I-5):
Figure BDA0002372646980000041
in the preparation method, the aromatic amine, the alkynylamine, the formic acid, the acetic anhydride, the palladium chloride and the triphenylphosphine are generally commercially available products and can be conveniently obtained from the market, the trifluoroethyliminecarbonyl chloride can be quickly synthesized from the corresponding aromatic amine, the triphenylphosphine, the carbon tetrachloride and the trifluoroacetic acid, and the diaryl iodide salt can be simply and quickly prepared from the corresponding aryl phenylboronic acid and the aryl iodide.
Compared with the prior art, the invention has the beneficial effects that: the preparation method is easy to operate, and the post-treatment is simple and convenient; the initial raw materials for the reaction are cheap and easy to obtain, the designability of the substrate is strong, the tolerance range of the functional group of the substrate is wide, the reaction efficiency is high, the imidazole compounds with trifluoromethyl and different substitutions at the 1 and 5 positions can be designed and synthesized according to actual needs, and the practicability is strong.
Detailed Description
The invention is further described with reference to specific examples.
According to the raw material ratio of table 1, palladium chloride, triphenylphosphine, acetic anhydride and formic acid mixture, sodium bicarbonate, trifluoroethylimidoyl chloride (II), propargylamine (III), diaryl Iodide (IV) and organic solvent 2m L are added into a Schlenk tube of 35m L, the mixture is uniformly mixed and stirred, the mixture reacts for 16 to 24 hours according to the reaction conditions of table 2, the mixture is filtered, silica gel is stirred, and the corresponding 2-trifluoromethyl substituted imidazole compound (I) is obtained through column chromatography purification, wherein the reaction process is shown as the following formula:
Figure BDA0002372646980000051
TABLE 1 raw material addition amounts of examples 1 to 15
Figure BDA0002372646980000052
Figure BDA0002372646980000061
TABLE 2
Figure BDA0002372646980000062
In tables 1 and 2, T is the reaction temperature, T is the reaction time, Ph is phenyl, Me is methyl, OMe is methoxy, T-Bu is T-butyl, NO2Is nitro, CF3Is trifluoromethyl and THF is tetrahydrofuran.
Structure confirmation data of the compounds prepared in examples 1 to 5:
nuclear magnetic resonance of 2-trifluoromethyl-substituted imidazole Compound (I-1) prepared in example 1 ((II-1))1H NMR、13C NMR and19f NMR) the data were:
Figure BDA0002372646980000063
1H NMR(400MHz,CDCl3)7.79(d,J=7.3Hz,2H),7.56(t,J=7.4Hz,1H),7.42(t,J=7.8Hz,2H),7.22(d,J=8.4Hz,2H),7.16(d,J=8.3Hz,2H),7.13(s,1H),4.07(s,2H),2.37(s,3H).
13C NMR(101MHz,CDCl3)194.5,140.4,136.9(q,J=38.6Hz),136.0,133.7,131.6,130.6,130.1,128.8,128.4,128.2,127.7,118.8(q,J=270.0Hz),34.1,21.3.
19F NMR(377MHz,CDCl3)-60.3.
HRMS(ESI):[M+H]+calcd.for C19H15F3N2O 345.1209,found 345.1227.
nuclear magnetic resonance of 2-trifluoromethyl-substituted imidazole Compound (I-2) prepared in example 2 ((II-2))1HNMR、13C NMR and19f NMR) the data were:
Figure BDA0002372646980000071
1H NMR(400MHz,CDCl3)7.76(d,J=7.2Hz,2H),7.55(t,J=7.4Hz,1H),7.42(d,J=8.4Hz,4H),7.19(d,J=8.5Hz,2H),7.13(s,1H),4.05(s,2H),1.30(s,9H).
13C NMR(101MHz,CDCl3)194.8,153.5,137.0(q,J=37.2Hz),136.2,133.7,131.6,130.7,128.8,128.4,128.2,127.5,126.4,118.8(q,J=270.0Hz),35.0,34.1,31.3.
19F NMR(377MHz,CDCl3)-60.3(s).
HRMS(ESI):[M+H]+calcd.for C22H21F3N2O 387.1679,found 387.1693.
nuclear magnetic resonance of 2-trifluoromethyl-substituted imidazole Compound (I-3) prepared in example 3 ((II-3))1HNMR、13C NMR and19f NMR) the data were:
Figure BDA0002372646980000072
1H NMR(400MHz,CDCl3)7.93(dd,J=16.5,7.9Hz,2H),7.57(dd,J=14.5,4.3Hz,3H),7.53–7.50(m,2H),7.47(dd,J=7.2,6.1Hz,2H),7.30(dd,J=10.6,4.9Hz,3H),7.12(d,J=8.3Hz,1H),3.90(dd,J=137.1,17.6Hz,2H).
13C NMR(101MHz,CDCl3)194.3,137.5(q,J=39.1Hz),135.8,134.0,133.6,131.4,130.9,130.4,130.3,128.8,128.7,128.5,128.3,128.1,127.2,127.1,125.1,122.7,118.7(q,J=270.1Hz),33.9.
19F NMR(377MHz,CDCl3)-61.1.
HRMS(ESI):[M+H]+calcd.for C22H15F3N2O 381.1209,found 381.1227.
nuclear magnetic resonance of 2-trifluoromethyl-substituted imidazole Compound (I-4) prepared in example 4 ((II-4))1HNMR、13C NMR and19f NMR) the data were:
Figure BDA0002372646980000081
1H NMR(400MHz,CDCl3)7.77(d,J=8.9Hz,2H),7.48–7.40(m,3H),7.29(dd,J=6.7,4.7Hz,2H),7.13(s,1H),6.88(d,J=8.9Hz,2H),4.02(s,2H),3.85(s,3H).
13C NMR(101MHz,CDCl3)192.9,164.0,136.7(q,J=39.0Hz),134.3,130.9,130.6,130.2,129.5,128.9,128.4,128.0,118.8(q,J=269.9Hz),114.0,55.6,33.8.
19F NMR(377MHz,CDCl3)-60.3.
HRMS(ESI):[M+H]+calcd.for C19H15F3N2O2361.1158,found 361.1174.
nuclear magnetic resonance of 2-trifluoromethyl-substituted imidazole Compound (I-5) prepared in example 5 ((II-5))1HNMR、13C NMR and19f NMR) the data were:
Figure BDA0002372646980000082
1H NMR(400MHz,CDCl3)7.72(d,J=8.6Hz,2H),7.48–7.41(m,3H),7.41–7.36(m,2H),7.28(d,J=5.7Hz,2H),7.15(s,1H),4.05(s,2H).
13C NMR(101MHz,CDCl3)193.3,140.3,136.9(q,J=39.0Hz),134.2,130.3,130.1,129.6,129.6,129.2,128.6,128.0,118.7(q,J=270.2Hz),34.1.
19F NMR(377MHz,CDCl3)-60.3.
HRMS(ESI):[M+H]+calcd.for C18H12ClF3N2O 365.0663,found 365.0678.

Claims (10)

1. a method for preparing a 2-trifluoromethyl-substituted imidazole compound, comprising the steps of: adding a palladium catalyst, a ligand, a carbon monoxide substitute, an additive, trifluoroethylimidoyl chloride, propargylamine and diaryl iodide into an organic solvent, reacting for 16-24 hours at 20-40 ℃, and after the reaction is completed, carrying out post-treatment to obtain the 2-trifluoromethyl-substituted imidazole compound;
the structure of the trifluoroethylimidoyl chloride is shown as a formula (II):
Figure FDA0002372646970000011
the propargylamine has a structure shown in a formula (III):
Figure FDA0002372646970000012
the structure of the diaryl iodonium salt is shown as the formula (IV):
Figure FDA0002372646970000013
the 2-trifluoromethyl substituted imidazole compound has a structure shown in a formula (I):
Figure FDA0002372646970000014
in the formulas (I) to (IV), R is substituted or unsubstituted aryl;
ar is a substituted or unsubstituted aryl group;
the substituent on the aryl is selected from C1~C5Alkyl, halogen, trifluoromethyl or nitro.
2. The method for producing a 2-trifluoromethyl-substituted imidazole compound according to claim 1, wherein R is a substituted or unsubstituted aryl group;
the substituent on the aryl is selected from methyl, tert-butyl, chlorine, bromine, trifluoromethyl or nitro.
3. The method for producing a 2-trifluoromethyl-substituted imidazole compound according to claim 1, wherein Ar is a substituted or unsubstituted phenyl group;
the substituent on the phenyl is selected from methoxy, methyl, chlorine or bromine.
4. The method for producing a 2-trifluoromethyl-substituted imidazole compound according to claim 1, wherein, in terms of molar amount, the ratio of trifluoroethylimidoyl chloride: propargylamine: diaryl iodonium salts: additive: palladium catalyst: ligand: the carbon monoxide substitute is 1-2: 1: 1-2: 8-10: 0.05:0.1: 2-4.
5. The method for preparing a 2-trifluoromethyl-substituted imidazole compound according to claim 1, wherein the organic solvent is tetrahydrofuran.
6. The method for preparing a 2-trifluoromethyl-substituted imidazole compound according to claim 1, wherein the palladium catalyst is palladium chloride.
7. The method for producing a 2-trifluoromethyl-substituted imidazole compound according to claim 1, wherein the ligand is triphenylphosphine.
8. The method for preparing a 2-trifluoromethyl-substituted imidazole compound according to claim 1, wherein the additive is a mixture of acetic anhydride and formic acid.
9. The method of claim 1, wherein the carbon monoxide substitute is sodium bicarbonate.
10. The method for preparing a 2-trifluoromethyl-substituted imidazole compound according to claim 1, wherein the 2-trifluoromethyl-substituted imidazole compound is one of compounds represented by formula (I-1) to formula (I-5):
Figure FDA0002372646970000021
Figure FDA0002372646970000031
CN202010055490.0A 2020-01-17 2020-01-17 Preparation method of 2-trifluoromethyl substituted imidazole compound Active CN111423381B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010055490.0A CN111423381B (en) 2020-01-17 2020-01-17 Preparation method of 2-trifluoromethyl substituted imidazole compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010055490.0A CN111423381B (en) 2020-01-17 2020-01-17 Preparation method of 2-trifluoromethyl substituted imidazole compound

Publications (2)

Publication Number Publication Date
CN111423381A true CN111423381A (en) 2020-07-17
CN111423381B CN111423381B (en) 2021-09-07

Family

ID=71547061

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010055490.0A Active CN111423381B (en) 2020-01-17 2020-01-17 Preparation method of 2-trifluoromethyl substituted imidazole compound

Country Status (1)

Country Link
CN (1) CN111423381B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112250636A (en) * 2020-11-09 2021-01-22 广西科技大学 5-aminoimidazole compound and synthesis method thereof
CN113307790A (en) * 2021-05-24 2021-08-27 杭州职业技术学院 Preparation method of 3-quinolyl-5-trifluoromethyl substituted 1,2, 4-triazole compound
CN113429349A (en) * 2021-07-20 2021-09-24 杭州职业技术学院 Preparation method of heterogeneous catalytic 2-trifluoromethyl substituted benzimidazole compound
CN113735778A (en) * 2020-12-23 2021-12-03 浙江理工大学 Preparation method of 5-trifluoromethyl substituted imidazole compound
CN115286609A (en) * 2022-08-09 2022-11-04 浙江理工大学 Preparation method of 2-trifluoromethyl substituted dihydrobenzo chromene
CN115417852A (en) * 2022-09-22 2022-12-02 华东师范大学 5-trifluoromethyl-4H-thiopyran derivative and preparation method thereof

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112250636A (en) * 2020-11-09 2021-01-22 广西科技大学 5-aminoimidazole compound and synthesis method thereof
CN113735778A (en) * 2020-12-23 2021-12-03 浙江理工大学 Preparation method of 5-trifluoromethyl substituted imidazole compound
CN113735778B (en) * 2020-12-23 2023-08-18 浙江理工大学 Preparation method of 5-trifluoromethyl substituted imidazole compound
CN113307790A (en) * 2021-05-24 2021-08-27 杭州职业技术学院 Preparation method of 3-quinolyl-5-trifluoromethyl substituted 1,2, 4-triazole compound
CN113307790B (en) * 2021-05-24 2022-03-18 杭州职业技术学院 Preparation method of 3-quinolyl-5-trifluoromethyl substituted 1,2, 4-triazole compound
CN113429349A (en) * 2021-07-20 2021-09-24 杭州职业技术学院 Preparation method of heterogeneous catalytic 2-trifluoromethyl substituted benzimidazole compound
CN115286609A (en) * 2022-08-09 2022-11-04 浙江理工大学 Preparation method of 2-trifluoromethyl substituted dihydrobenzo chromene
CN115286609B (en) * 2022-08-09 2023-12-19 浙江理工大学 Preparation method of 2-trifluoromethyl substituted dihydrobenzochromene
CN115417852A (en) * 2022-09-22 2022-12-02 华东师范大学 5-trifluoromethyl-4H-thiopyran derivative and preparation method thereof
CN115417852B (en) * 2022-09-22 2023-12-01 华东师范大学 5-trifluoromethyl-4H-thiopyran derivatives and process for preparing same

Also Published As

Publication number Publication date
CN111423381B (en) 2021-09-07

Similar Documents

Publication Publication Date Title
CN111423381B (en) Preparation method of 2-trifluoromethyl substituted imidazole compound
CN111978265B (en) Preparation method of 5-trifluoromethyl substituted 1,2, 4-triazole derivative
CN111675662B (en) Preparation method of 2-trifluoromethyl substituted quinazolinone compound
CN110467579B (en) Preparation method of 5-trifluoromethyl substituted 1,2, 4-triazole compound
CN113105402B (en) Preparation method of 3,4, 5-trisubstituted 1,2, 4-triazole compound
CN113121462B (en) Preparation method of 5-trifluoromethyl substituted 1,2,3-triazole compound
CN112125856A (en) Preparation method of 2-trifluoromethyl substituted quinazolinone derivative
CN113307790B (en) Preparation method of 3-quinolyl-5-trifluoromethyl substituted 1,2, 4-triazole compound
CN113307778A (en) Preparation method of 3-trifluoromethyl substituted 1,2, 4-triazole compound
CN113045489A (en) Preparation method of 3-arylquinoline-2 (1H) ketone derivative
CN112480015B (en) Method for synthesizing 2-trifluoromethyl substituted quinazolinone by multi-component one-pot method
CN113045503B (en) Preparation method of 2-trifluoromethyl substituted quinazolinone compound and application of compound in synthesis of drug molecules
CN113735778B (en) Preparation method of 5-trifluoromethyl substituted imidazole compound
CN115260080B (en) Preparation method of indole-3-formamide compound
CN113511986B (en) Preparation method of aryl acetonitrile derivative
CN112694430B (en) Preparation method of 1, 5-dihydro-2H-pyrrole-2-ketone compound
CN111978194B (en) Preparation method of aryl acetamide compound
CN113880781A (en) Method for synthesizing 3-trifluoromethyl substituted 1,2, 4-triazole compound by taking glucose as carbon source
CN112239456B (en) Preparation method of substituted 2, 3-dihydroquinolone compound
CN115353511A (en) Method for synthesizing carbonyl bridged bis-heterocyclic compound from multiple components
CN116640146A (en) Preparation method of trifluoromethyl substituted chromone quinoline
CN115286553B (en) Preparation method of indole compound
CN115385895A (en) Preparation method of 2-trifluoromethyl substituted indole compound
CN114751883B (en) Preparation method of benzofuran-3-carboxamide compound
CN113735826B (en) Preparation method of 3-benzylidene-2, 3-dihydroquinolone compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant